Downloads
Abstract
Background: Increasing age is the most prevalent, primary risk factor for breast cancer. However, the treatment of breast cancer in older women were less active than younger women and there is a relative lack of evidence-based guidelines to inform the treatment of breast cancer in elderly woman. In this study, we evaluated the results of treatment of breast cancer in elderly woman based on the tumor characteristics.
Material and methods: This study was designed with 60 breast cancer patients older than 65 years old. Evaluation of clinical, subclinical characteristics and treatment results initially (disease-free survival and total survival after 2 years) of this group.
Results: We conducted a study of 60 elderly woman with breast cancer. The majority of patients with invasive ductal carcinoma (90%), histological grade I, II (76,3%) and the patients with stage I, II disease were 80,4%. The older patients have been found to have a greater frequency of molecular subtypes: luminal A and B (34% and 22%), however the triple-negative/basal-like was 28%. The rate of modified radical mastectomy was 93,3%, only 46,4% of patients received adjuvant therapy (chemotherapy, radiation therapy, hormonal therapy and antibody therapy). Local recurrence and distant metastasis were 11,7% and 18,3%, mortality was 16,7% with a median follow-up of 28,03 months.
Conclusions: Breast carcer in older patients has better prognosis factors than younger women. However, current adjuvant systemic therapy options for older women with breast cancer was not clear.
References
Nguyễn Văn Phong (2014), Đánh giá kết quả điều trị ung thư vú bằng phẫu thuật cắt vú triệt để cải biên, Luận văn Thạc sĩ y học, Trường Đại học Y Dược, Đại học Huế.
Trần Hữu Phúc (2018), Đánh giá kết quả phẫu thuật điều trị ung thư vú và nghiên cứu sự liên quan giữa kích thước khối u và tình trạng di căn hạch nách trong ung thư vú, Luận văn Thạc sĩ y học, Trường Đại học Y Dược, Đại học Huế.
Barthélémy P et al (2011), “Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals”, Critical Reviews in Oncology/Hematology, 79(2), pp. 196-204.
Bastiaannet E., Liefers G.J., de Craen A.J., et al (2010), “Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients”, Breast Cancer Res Treat, 124(3), pp. 801-807.
Chris E. Holmes, Hyman B. Muss (2003), “Diagnosis and treatment of breast cancer in elderly”, CA Cancer J Clin, 53 (4), pp. 227-244
Diab S.G., Elledge R.M., Clark G.M. (2000), “Tumor characteristics and clinical outcome of elderly women with breast cancer”, J Natl Cancer Inst, 92(7), pp. 550-556.
Gennari R., Curigliano G., Rotmensz N., et al (2004), “Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients”, Cancer, 101(6), pp. 1302-1310.
Globocan (2018), “Breast Cancer - Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2018”, Global Cancer Observatory.
Haddad A., Zoukar O., Daldoul A., et al (2018), “Breast diseases in women over the age of 65 in Monastir, Tunisia”, Pan African Medical Journal, 2018, pp. 31-67.
Kemeny M.M., Busch‐Devereaux E., Merriam L.T., et al (2000), “Cancer surgery in the elderly”, Hematol Oncol Clin North Am, 14, pp. 169–192.
Malik M.K., Tartter P.I., Belfer R. (2013), “Undertreated breast cancer in the elderly”, J Cancer Epidemiol, 2013, pp. 893104.
N A de Glas, E Bastiaanner et all (2016), “Validity of the online PREDICT tool in older patients with breast cancer: a population-based stude”, Bristish journal of cancer, 114, pp. 395-400
Rodrigues N.A., Dillon D., Carter D., et al (2003), “Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women”, Cancer, 98(5), pp. 1102-1103.
Sami G. Diab, Richard M. Elledege, Gary M. Clark (2000), “Tumor characteristics and clinical outcome of elderly women with breast cancer”, Journal of the national cancer institute, vol 92 (7), pp. 550-556
Schonberg M.A., Marcantonio E.R., Li D., et al (2010), “Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival”, J Clin Oncol, 28(12), pp. 2038-2045.
Shah S., et al (2002), “Breast Cancer Recurrences in Elderly Patients After Lumpectomy”, Am Surg, 68(8), pp. 735-739.
Van Belle V., Van Calster B., Brouckaert O., et al (2010), “Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis”, J Clin Oncol, 28(27), pp. 4129-4134.
Yancik R., Wesley M.N., Ries L.A., et al (2001), “Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older”, JAMA, 285, pp. 885-889
| Published | 21-12-2020 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 66 (2020) | |
| Section | Original article | |
| DOI | 10.38103/jcmhch.2020.66.9 | |
| Keywords | Ung thư biểu mô tuyến vú phụ nữ lớn tuổi, phân nhóm sinh học phân tử ung thư vú, nhóm bộ ba âm tính, tỷ lệ sống còn không bệnh, tỷ lệ sống còn toàn bộ Breast cancer in elderly woman, molecular subtypes of breast cancer, triple-negative/basal- like group, disease-free survival rate, overall survival rate |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Journal of Clinical Medicine Hue Central Hospital